Eshoo bill huge boon for Silicon Valley biotech
Buried in the giant health care bills in Congress is a multibillion-dollar bonanza for Silicon Valley’s biotechnology and venture capital industries, sponsored by Rep. Anna Eshoo, a Palo Alto Democrat.
The provision would grant “biologic” drugs, a new class of drugs based on gene splicing and grown in living cells, 12 years of protection from competition by the generic drug industry, in addition to their patents.
A scathing report by the Federal Trade Commission in June said no added protection, much less 12 years, was warranted, and warned that the Eshoo legislation would ensure sky-high drug prices and stifle innovation on the most promising frontier of medical research.
Please consider making a donation to Rheumatoid Arthritis Guy.
- The New York Times: Actress, Artist, Sometimes Both At OnceMay 20, 2014 - 10:29 am
- The Columbian: Arthritis Not stopping 20-Year-Old Nursing StudentApril 15, 2014 - 3:25 pm
- Show Us Your Hands! Seeks Director Of FinanceJanuary 9, 2014 - 6:53 pm
- Show Us Your Hands! Annual Report: Building Foundations for the FutureDecember 17, 2013 - 5:24 pm
- Show Us Your Hands! Annual Report: Our Hands Can! Community StoriesDecember 16, 2013 - 1:51 pm